BACK TO TOP
KSE100
166,283.55
0.00
(0.00%)
KSE100PR
52,238.13
0.00
(0.00%)
ALLSHR
100,743.06
0.00
(0.00%)
KSE30
50,481.85
0.00
(0.00%)
KMI30
238,092.04
0.00
(0.00%)
BKTI
45,081.47
0.00
(0.00%)
OGTI
33,080.66
0.00
(0.00%)
KMIALLSHR
65,617.46
0.00
(0.00%)
PSXDIV20
73,055.05
0.00
(0.00%)
UPP9
57,001.02
0.00
(0.00%)
NITPGI
42,770.73
0.00
(0.00%)
NBPPGI
47,038.97
0.00
(0.00%)
MZNPI
29,344.03
0.00
(0.00%)
JSMFI
44,321.95
0.00
(0.00%)
ACI
23,729.00
0.00
(0.00%)
JSGBKTI
66,062.50
0.00
(0.00%)
HBLTTI
17,692.00
04-12-2025
5.25
(0.03%)
MII30
21,782.42
0.00
(0.00%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.86.43
0.46
(0.53%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Thu, Dec 4, 2025 3:49 PM
REG
DFC
CSF
ODL
Open
85.55
High
87.00
Low
85.50
Volume
899,748
CIRCUIT BREAKER
77.79 — 95.07
DAY RANGE
85.50 — 87.00
52-WEEK RANGE ^
49.02 — 109.30
Ask Price
78.00
Ask Volume
1
Bid Price
95.00
Bid Volume
2,000
LDCP
86.43
VAR
13.00
HAIRCUT
17.50
P/E Ratio (TTM) **
22.10
1-Year Change * ^
73.21%
YTD Change * ^
26.90%
Last update: Thu, Dec 4, 2025 3:36 PM
Open
0.00
High
0.00
Low
0.00
Close
87.23
Change
0.00%
LDCP
87.23
Volume
0
Total Trades
111
CIRCUIT BREAKER
78.51 — 95.95
DAY RANGE
0.00 — 0.00
Ask Price
89.25
Ask Volume
3,000
Bid Price
86.00
Bid Volume
5,000
Last update: Sun, Nov 30, 2025 6:07 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
87.23
Volume
0
Total Trades
0
CIRCUIT BREAKER
78.51 — 95.95
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Nov 30, 2025 6:07 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
89.52
Volume
0
Total Trades
0
CIRCUIT BREAKER
80.57 — 98.47
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Nov 30, 2025 6:07 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
88.50
Volume
0
Total Trades
0
CIRCUIT BREAKER
79.65 — 97.35
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Ghulam DastgeerCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
19,745,901.52
Shares
228,461,200
Free Float
114,230,600
Free Float
50.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2025TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED View   PDF
Oct 29, 2025Financial Results for the Quarter Ended View   PDF
Oct 7, 2025Transmission of Annual Report for the Year Ended View   PDF
Oct 2, 2025Financial Results for the year ended View   PDF
May 2, 2025Transmission of financial statements for the Nine Months period ended 31 March 2025 View   PDF
DateTitleDocument
Nov 13, 2025Certified True Copy of the Resolutions Passed in the Annual General Meeting View   PDF
Oct 29, 2025Board Meeting Other Than Financial Results (Post Election BOD Meeting) View   
Oct 24, 2025Board Meeting View   
Oct 6, 2025Notice of Annual General Meeting View   PDF
Sep 25, 2025Board Meeting View   
DateTitleDocument
Nov 6, 2025Credit of Final Cash Dividend (2025) View   PDF
Oct 20, 2025Notice of Election of Directors u/s 159(4) of the Companies Act, 2017 View   PDF
Oct 16, 2025CLARIFICATION REGARDING NEWS CIRCULATING ON SOCIAL MEDIA PLATFORMS View   PDF
Sep 12, 2025Material Information View   PDF
Aug 6, 2025Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
REVOKED
View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,153,52112,409,23912,396,9839,779,880
Profit after Taxation892,039833,464657,984635,884
EPS3.903.652.882.88
Q1 2026Q3 2025Q2 2025Q1 2025
Sales3,370,2473,341,1083,534,4323,224,645
Profit after Taxation203,691220,375256,979201,497
EPS0.890.961.120.88
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)15.3412.7812.1613.83
Net Profit Margin (%)6.786.725.316.50
EPS Growth (%)6.8526.74(20.88)
PEG3.140.29(0.54)

Payouts

DateFinancial ResultsDetailsBook Closure
October 2, 2025 4:35 PM30/06/2025(YR) 35%(F) (D) 21/10/2025 - 27/10/2025
October 2, 2024 2:52 PM30/06/2024(YR) 32.50%(F) (D) 21/10/2024 - 28/10/2024
September 28, 2023 4:07 PM30/06/2023(YR) 25%(F) (D) 20/10/2023 - 27/10/2023
September 30, 2021 9:32 PM30/06/2021(YR) 15% (D) - 10% (B) 21/10/2021 - 28/10/2021

Financial Reports